ALLMedicine™ Inflammatory Bowel Disease Center

Feb 27th, 2021 - While the pathogenesis of inflammatory bowel disease (IBD) is incompletely understood, disruption of epithelial integrity is suspected to play a prominent role in disease initiation and progression. Currently, there is no convenient way to measure...

Feb 27th, 2021 - To assess bowel dose-volume relationships for acute patient-reported intestinal symptoms of patients treated with whole-pelvis intensity-modulated radiotherapy (WPRT) for prostate cancer. Complete data of 415 patients enrolled in a multi institute...

Feb 27th, 2021 - Heme is an important iron-containing porphyrin molecule expressed ubiquitously in organisms. Recently, this endogenous molecule has been widely reported to be involved in the pathogenesis of numerous diseases such as sepsis, atherosclerosis and in...

Feb 26th, 2021 - Postoperative complication rates in patients with inflammatory bowel disease (IBD) receiving preoperative biologics have been analyzed without considering the surgical context. Emergency surgery may be associated with an increased risk of infectio...

Feb 26th, 2021 - To compare enteropathic spondylitis (ES) with psoriatic spondylitis (PS) and ankylosing spondylitis (AS), in patients on biological disease-modifying anti-rheumatic drug (bDMARD) treatment. Patients who were enrolled in the HUR-BIO registry were i...

Feb 13th, 2021 - The purpose of this expert review is to describe the role of medications for the chemoprevention of colorectal neoplasia. Neoplasia is defined as precancerous lesions (e.g., adenoma and sessile serrated lesion) or cancer. The scope of this review ...

Feb 6th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Oct 21st, 2020 - Endoscopy is an essential component in the management of inflammatory bowel disease [IBD]. There is a risk of SARS-CoV-2 transmission during endoscopic procedures. The International Organization for the study of IBD [IOIBD] has developed 11 positi...

Oct 4th, 2020 - AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Elderly Patients: Expert Review.|2020|Ananthakrishnan AN,Nguyen GC,Bernstein CN,|

Sep 22nd, 2020 - Infusion centres are a central part in the management of patients with inflammatory bowel disease [IBD] and could be a source of transmission of SARS-COV-2. Here we aimed to develop global guidance for best practices of infusion centres for IBD pa...

Feb 27th, 2021 - While the pathogenesis of inflammatory bowel disease (IBD) is incompletely understood, disruption of epithelial integrity is suspected to play a prominent role in disease initiation and progression. Currently, there is no convenient way to measure...

Feb 27th, 2021 - To assess bowel dose-volume relationships for acute patient-reported intestinal symptoms of patients treated with whole-pelvis intensity-modulated radiotherapy (WPRT) for prostate cancer. Complete data of 415 patients enrolled in a multi institute...

Feb 27th, 2021 - Heme is an important iron-containing porphyrin molecule expressed ubiquitously in organisms. Recently, this endogenous molecule has been widely reported to be involved in the pathogenesis of numerous diseases such as sepsis, atherosclerosis and in...

Feb 26th, 2021 - Postoperative complication rates in patients with inflammatory bowel disease (IBD) receiving preoperative biologics have been analyzed without considering the surgical context. Emergency surgery may be associated with an increased risk of infectio...

Feb 26th, 2021 - To compare enteropathic spondylitis (ES) with psoriatic spondylitis (PS) and ankylosing spondylitis (AS), in patients on biological disease-modifying anti-rheumatic drug (bDMARD) treatment. Patients who were enrolled in the HUR-BIO registry were i...

Feb 21st, 2021 - NEW YORK (Reuters Health) - A subset of macrophages, PTGER4+ (EP4+), are the major drivers of epithelial regeneration after intestinal inflammation and are potential targets for inflammatory bowel disease (IBD) therapy, researchers say. "Dysfuncti...

Feb 18th, 2021 - NEW YORK (Reuters Health) - The monoclonal antibody ustekinumab (Stelara, Janssen) appears to be at least as effective against ulcerative colitis (UC) in real-world practice as it was in the clinical trials that led to its approval, according to n...

Feb 16th, 2021 - Patients with advanced melanoma and preexisting autoimmune diseases (AIDs) who were treated with immune checkpoint inhibitors (ICIs) responded well and did not suffer more grade 3 or higher immune-related adverse events than patients without an AI...

Feb 15th, 2021 - (Reuters Health) - Children with Hirschsprung disease may be at increased risk for developing inflammatory bowel disease, a Canadian study suggests. Researchers examined data on 716 children diagnosed with Hirschsprung since 1991 in Ontario, as we...

Feb 11th, 2021 - A large analysis of Medicare data from all 50 states suggests that vedolizumab may be just as effective as anti–tumor necrosis factor (anti-TNF) agents in controlling inflammatory bowel disease (IBD) in patients aged over 65 years, with fewer infe...